Payer+Provider's Health System Review
The New Techno-Fusion: The Merging Of Technologies Impacting Our Future
Why Abbvie May Have A Tough Time Defending Humira’s Price Before Congress
February 26, 2019
The latest talc-asbestos trial is underway in New Jersey, where plaintiffs have scored eight- and nine-figure verdicts.
Read the full post on Forbes - Healthcare